Singletto's Oxafence Active Protection™ technology represents a significant advancement in pathogen protection by actively inactivating harmful microorganisms rather than merely trapping them. Utilizing Antimicrobial Photodynamic Inactivation (aPDI), this technology employs protective dyes such as Methylene Blue and Riboflavin (Vitamin B2) to generate singlet oxygen, which is known for its antimicrobial properties. This method allows for ongoing pathogen inactivation during the use of treated materials, making it applicable across various sectors, including healthcare, military, and consumer products. The technology has shown efficacy against a range of pathogens, including SARS-CoV-2 and H1N1, and is designed to be integrated into commonly used fabrics and materials.

The formulation of Oxafence technology is notable for its simplicity and scalability, relying on low concentrations of well-understood protective dyes rather than expensive or hazardous substances. This approach not only facilitates easy incorporation into existing manufacturing processes but also addresses the growing concern of antimicrobial resistance, as pathogens are unlikely to develop resistance to singlet oxygen. Singletto's ongoing research and collaboration with global health organizations further enhance the credibility and potential of this innovative technology, positioning it as a promising solution for effective pathogen control in various applications.

United States

Active Protection™ from Pathogens. Confidence to Live Well. Singletto's novel Oxafence® technology is being developed to meet the needs of healthcare, military, industry, and consumers - providing ongoing Active Protection from pathogens where it matters most.

Singletto

Company Details